--- title: "Wuxi Biologics (Cayman) (2269) stock and investor profile" url: "https://aibio.space/companies/wuxi-biologics-cayman/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Wuxi Biologics (Cayman) Inc. (HKEX: 2269), China. The directory classifies it as Biotechnology." --- 2269 Wuxi Biologics (Cayman) Inc. HKEX · China # Wuxi Biologics (Cayman) (2269) news Wuxi Biologics (Cayman) Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2269, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Wuxi Biologics (Cayman) news We have not published a story on Wuxi Biologics (Cayman) yet. When there is news, it will appear here. ## Wuxi Biologics (Cayman) at a glance - **Ticker**: 2269 - **Listing**: HKEX - **Country**: China ### Related companies - [Beijing Luzhu Biotechnology Co.](https://aibio.space/companies/beijing-luzhu-biotechnology/) HKEX: 2480 - [Boji Medical Technology Co.](https://aibio.space/companies/boji-medical-technology/) SZSE: 300404 - [Beijing Kawin Technology Share-Holding Co.](https://aibio.space/companies/beijing-kawin-technology-share/) SSE: 688687 - [Hebei Changshan Biochemical Pharmaceutical Co.](https://aibio.space/companies/hebei-changshan-biochemical-pharmaceutical/) SZSE: 300255 - [GemPharmatech Co.](https://aibio.space/companies/gempharmatech/) SSE: 688046 - [3SBio](https://aibio.space/companies/3sbio/) HKEX: 1530 - [Pacific Shuanglin Bio-pharmacy Co.](https://aibio.space/companies/pacific-shuanglin-bio-pharmacy/) SZSE: 000403 - [Shanghai Shen Lian Biomedical](https://aibio.space/companies/shanghai-shen-lian-biomedical/) SSE: 688098 ### Also on HKEX - [Zhongzhi Pharmaceutical Holdings](https://aibio.space/companies/zhongzhi-pharmaceutical/) 3737 - [ImmuneOnco Biopharmaceuticals (Shanghai)](https://aibio.space/companies/immuneonco-biopharmaceuticals-shanghai/) 1541 - [Antengene Corporation](https://aibio.space/companies/antengene/) 6996 - [Hightide Therapeutics](https://aibio.space/companies/hightide-therapeutics/) 2511 - [China Medical System Holdings](https://aibio.space/companies/china-medical-system/) 867 - [Tianda Pharmaceuticals](https://aibio.space/companies/tianda-pharmaceuticals/) 455 ## Questions about Wuxi Biologics (Cayman) What is the ticker symbol of Wuxi Biologics (Cayman)? Wuxi Biologics (Cayman) Inc. trades under the ticker 2269 on HKEX. Where is Wuxi Biologics (Cayman) listed? Wuxi Biologics (Cayman) Inc. is listed on HKEX. Our directory also records these other listings: GETTEX:1FW2; LS:A2QJCN; LSX:A2QJCN; OTC:WXIBF; OTC:WXXWY; SET:WUXI06; SET:WUXI13. Which country or territory is Wuxi Biologics (Cayman) listed under? Our directory records Wuxi Biologics (Cayman) Inc. under China. What does Wuxi Biologics (Cayman) do? Our directory classifies Wuxi Biologics (Cayman) Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Wuxi Biologics (Cayman)? The ISIN recorded for Wuxi Biologics (Cayman) Inc. is KYG970081173. Does aibio.space cover Wuxi Biologics (Cayman)? aibio.space lists Wuxi Biologics (Cayman) Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Wuxi Biologics (Cayman)? Companies in our directory listed in the same country and business area as Wuxi Biologics (Cayman): Beijing Luzhu Biotechnology Co., Boji Medical Technology Co., Beijing Kawin Technology Share-Holding Co., Hebei Changshan Biochemical Pharmaceutical Co., GemPharmatech Co., 3SBio. ## Investor discussion: Wuxi Biologics (Cayman) Members talk about Wuxi Biologics (Cayman) (2269). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Wuxi Biologics (Cayman), newest first. Each line links the filing it comes from. 1. 2026-01-14 Mergers Transaction under the Listing Rules: Joint Announcement. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0114/2026011401580.pdf) 2. 2025-01-06 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - ASSET TRANSACTION RELATED TO VACCINES IRELAND FACILITY. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0106/2025010601896.pdf) ## Press releases Headlines of Wuxi Biologics (Cayman)'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-08-25 HKEXnews [INSIDE INFORMATION - 2026 INTERIM RESULTS PRESENTATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0825/2026082501449.pdf) 2. 2026-08-25 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0825/2026082500945.pdf) 3. 2026-06-10 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 10, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0610/2026061001276.pdf) 4. 2026-06-09 HKEXnews [GRANT OF RESTRICTED SHARES UNDER RESTRICTED SHARE AWARD SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0609/2026060901214.pdf) 5. 2026-05-31 HKEXnews [INSIDE INFORMATION - PRESENTATION AT 2026 BUSINESS UPDATE MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0531/2026053100003.pdf) 6. 2026-05-26 HKEXnews [VOLUNTARY ANNOUNCEMENT - PROPOSED ON-MARKET SHARE REPURCHASE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052600133.pdf) 7. 2026-05-19 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0519/2026051900264.pdf) 8. 2026-03-24 HKEXnews [INSIDE INFORMATION - 2025 ANNUAL RESULTS PRESENTATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0324/2026032401077.pdf) 9. 2026-03-24 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0324/2026032400734.pdf) 10. 2026-02-10 HKEXnews [POSITIVE PROFIT ALERT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0211/2026021100031.pdf) 11. 2026-01-15 HKEXnews [INSIDE INFORMATION - PLACING OF EXISTING SHARES BY SUBSTANTIAL SHAREHOLDER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0116/2026011600043.pdf) 12. 2026-01-14 HKEXnews [Joint Announcement](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0114/2026011401580.pdf) 13. 2026-01-11 HKEXnews [INSIDE INFORMATION - PRESENTATION AT 2026 ANNUAL HEALTHCARE CONFERENCE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0111/2026011100017.pdf) 14. 2025-09-02 HKEXnews [CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE PAYLOAD-LINKERS MASTER SERVICES AGREEMENTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0902/2025090201614.pdf) 15. 2025-08-19 HKEXnews [INSIDE INFORMATION - 2025 INTERIM RESULTS PRESENTATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0819/2025081901340.pdf) 16. 2025-08-19 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0819/2025081901288.pdf) 17. 2025-06-15 HKEXnews [INSIDE INFORMATION - PLACING OF EXISTING SHARES BY SUBSTANTIAL SHAREHOLDER](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0616/2025061600017.pdf) 18. 2025-06-06 HKEXnews [(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 6, 2025; (2) CHANGE OF DIRECTOR; AND (3) CHANGE IN COMPOSITION OF BOARD COMMITTEES](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0606/2025060601377.pdf) 19. 2025-03-26 HKEXnews [GRANT OF RESTRICTED SHARES UNDER RESTRICTED SHARE AWARD SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0326/2025032601438.pdf) 20. 2025-03-25 HKEXnews [INSIDE INFORMATION - 2024 ANNUAL RESULTS PRESENTATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0325/2025032501097.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2269 on TradingView](https://www.tradingview.com/symbols/HKEX-2269/). ## Listing details Wuxi Biologics (Cayman) Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2269, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Wuxi Biologics (Cayman) Inc. - **Ticker**: 2269 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: KYG970081173 - **Other listed symbols**: GETTEX:1FW2; LS:A2QJCN; LSX:A2QJCN; OTC:WXIBF; OTC:WXXWY; SET:WUXI06; SET:WUXI13 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2269/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/wuxi-biologics-cayman/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Wuxi Biologics (Cayman) (2269) stock and investor profile", 2026-10-31, https://aibio.space/companies/wuxi-biologics-cayman/